Bio-Techne CorporationTECHNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank59
3Y CAGR-11.4%
5Y CAGR+29.8%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-11.4%/yr
Quarterly compound
5Y CAGR
+29.8%/yr
Recent deceleration
Percentile
P59
Within normal range
vs 5Y Ago
3.7x
Strong expansion
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 14.27% |
| Q3 2025 | 299.74% |
| Q2 2025 | -161.64% |
| Q1 2025 | -18.37% |
| Q4 2024 | 18.59% |
| Q3 2024 | -12.74% |
| Q2 2024 | -31.61% |
| Q1 2024 | 76.29% |
| Q4 2023 | -31.97% |
| Q3 2023 | -40.90% |
| Q2 2023 | 17.85% |
| Q1 2023 | 18.15% |
| Q4 2022 | 20.55% |
| Q3 2022 | -30.10% |
| Q2 2022 | -10.92% |
| Q1 2022 | 45.07% |
| Q4 2021 | -1.38% |
| Q3 2021 | -7.82% |
| Q2 2021 | -0.06% |
| Q1 2021 | 34.57% |
| Q4 2020 | 3.88% |
| Q3 2020 | 24.88% |
| Q2 2020 | -17.75% |
| Q1 2020 | 29.19% |
| Q4 2019 | 11.00% |
| Q3 2019 | -22.97% |
| Q2 2019 | -1.88% |
| Q1 2019 | 31.21% |
| Q4 2018 | 30.43% |
| Q3 2018 | -39.97% |
| Q2 2018 | -0.39% |
| Q1 2018 | 78.42% |
| Q4 2017 | -7.23% |
| Q3 2017 | -37.24% |
| Q2 2017 | 28.39% |
| Q1 2017 | 100.08% |
| Q4 2016 | -36.54% |
| Q3 2016 | -36.41% |
| Q2 2016 | -8.08% |
| Q1 2016 | 20.82% |